MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma.
Sophia F MagkoutaPhotene C VaitsiMarianthi P IliopoulouApostolos Georgios PappasChrysavgi N KostiKatherina PsarraIoannis T KalomenidisPublished in: Cancers (2023)
Combined MTH1 and PD-L1 inhibition holds promise for the successful clinical management of mesothelioma.
Keyphrases